We are live on ! Find out more
AIM

Aigen Investment Management Portfolio holdings

AUM $389M
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$55.2M
Cap. Flow
+$68.6M
Cap. Flow %
13.33%
Top 10 Hldgs %
9.21%
Holding
1,071
New
432
Increased
168
Reduced
133
Closed
338

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$5.06M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.91M
3
AZO icon
AutoZone
AZO
+$4.44M
4
PSX icon
Phillips 66
PSX
+$4.04M
5
RTX icon
RTX Corp
RTX
+$3.95M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.63M
2
AWK icon
American Water Works
AWK
+$4.76M
3
ROST icon
Ross Stores
ROST
+$4.03M
4
LIN icon
Linde
LIN
+$3.44M
5
AAPL icon
Apple
AAPL
+$3.19M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.15%
2 Technology 15.58%
3 Industrials 13.47%
4 Financials 11.94%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNIT
676
Uniti Group
UNIT
$2.32B
$125K 0.02%
42,893
-5,405
-11% -$22.6K
GERN icon
677
Geron
GERN
$949M
$125K 0.02%
+29,519
New +$115K
ARI
678
Apollo Commercial Real Estate
ARI
$885M
$125K 0.02%
+12,762
New +$132K
UGP icon
679
Ultrapar
UGP
$6.54B
$125K 0.02%
+31,915
New +$153K
MTW icon
680
Manitowoc
MTW
$675M
$122K 0.02%
+10,586
New +$131K
GPRO icon
681
GoPro
GPRO
$126M
$122K 0.02%
85,880
+40,669
+90% +$67.9K
BYND icon
682
Beyond Meat
BYND
$277M
$122K 0.02%
+18,173
New +$129K
INFN
683
DELISTED
Infinera Corporation Common Stock
INFN
$120K 0.02%
19,752
+7,401
+60% +$39.1K
FULC icon
684
Fulcrum Therapeutics
FULC
$297M
$120K 0.02%
+19,311
New +$146K
MD icon
685
Pediatrix Medical
MD
$2.2B
$119K 0.02%
+15,722
New +$130K
SHYF
686
DELISTED
The Shyft Group
SHYF
$119K 0.02%
+10,003
New +$120K
CNDT icon
687
Conduent
CNDT
$264M
$118K 0.02%
+36,334
New +$123K
ABEV icon
688
Ambev
ABEV
$46.4B
$118K 0.02%
+57,776
New +$132K
GOTU icon
689
Gaotu Techedu
GOTU
$436M
$118K 0.02%
+24,104
New +$151K
ARCO icon
690
Arcos Dorados Holdings
ARCO
$1.74B
$115K 0.02%
+12,742
New +$131K
CDE icon
691
Coeur Mining
CDE
$17.9B
$113K 0.02%
+20,156
New +$104K
TRTX
692
TPG RE Finance Trust
TRTX
$618M
$113K 0.02%
13,106
+2,853
+28% +$23.4K
BLND icon
693
Blend Labs
BLND
$386M
$111K 0.02%
+47,172
New +$125K
BHC icon
694
Bausch Health
BHC
$2.34B
$111K 0.02%
+15,863
New +$120K
HCSG icon
695
Healthcare Services Group
HCSG
$1.53B
$108K 0.02%
+10,255
New +$114K
HMY icon
696
Harmony Gold Mining
HMY
$12.3B
$107K 0.02%
+11,706
New +$105K
KRNY icon
697
Kearny Financial
KRNY
$599M
$105K 0.02%
+17,032
New +$97.4K
BKD icon
698
Brookdale Senior Living
BKD
$3.4B
$105K 0.02%
15,313
-3,047
-17% -$20.6K
BCRX icon
699
BioCryst Pharmaceuticals
BCRX
$2.4B
$101K 0.02%
16,381
-24,720
-60% -$136K
MRSN
700
DELISTED
Mersana Therapeutics
MRSN
$101K 0.02%
2,003
+1,022
+104% +$73.9K
26 27
28
29 30

Similar funds

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Aigen Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Aigen Investment Management held 1,071 positions worth $514M, up 12% from $459M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Aigen Investment Management deployed $68.6M of net new capital in Q2 2024, opening 432 new positions and adding to 168 existing holdings. Its largest new stake was Visa: 18,454 shares worth $4.84M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hess, an estimated $2.91M trimmed.

  • Aigen Investment Management's largest Q2 2024 buy was Visa: 18,454 shares worth $4.84M.
  • Aigen Investment Management added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.91M increase.
  • Aigen Investment Management's biggest Q2 2024 reduction was Hess, cutting an estimated $2.91M.
  • Aigen Investment Management fully exited Eli Lilly in Q2 2024, selling an estimated $6.63M.
  • Aigen Investment Management's ten largest holdings make up 9.2% of its $514M portfolio in Q2 2024.
  • Aigen Investment Management opened 432 new positions and closed 338 in Q2 2024.
  • Aigen Investment Management's portfolio value rose 12% quarter-over-quarter to $514M.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.